Nirmatrelvir-ritonavir for outpatients with COVID-19. Case-based approach to assessment and treatment

被引：0
|
作者：
LeBras, Marlys [1 ]
Crawley, Alex [2 ]
Legge, Marc [3 ]
Takaya, Satchan [4 ]
Lee, Stephen [5 ]
Regier, Loren [3 ]
机构：
[1] Univ Saskatchewan, Programme Format Continue Pharmacotherapie, Saskatoon, SK, Canada
[2] Univ Saskatchewan, Programme Format Continue Pharmacotherapie RxFile, Saskatoon, SK, Canada
[3] Programme Format Continue Pharmacotherapie, Saskatoon, SK, Canada
[4] Univ Saskatchewan, Coll Med, Div Malad Infect, Saskatoon, SK, Canada
[5] Univ Saskatchewan, Coll Med, Malad Infect & Med Interne, Saskatoon, SK, Canada
来源：
CANADIAN FAMILY PHYSICIAN | 2023年 / 69卷 / 08期
关键词：
D O I：
10.46747/cfp.6908e170
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
[No abstract available]
引用
收藏
页码：E170 / E174
页数：5
相关论文
共 50 条
  • [1] Nirmatrelvir-ritonavir (Paxlovid®), a treatment for Covid-19
    Buxeraud, Jacques
    Faure, Sebastien
    Fougere, Edouard
    ACTUALITES PHARMACEUTIQUES, 2020, 61 (617): : 10 - 12
  • [2] Nirmatrelvir-ritonavir for COVID-19
    McDonald, Emily G.
    Lee, Todd C.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (06) : E218 - E218
  • [3] Nirmatrelvir-ritonavir for nonhospitalized patients with COVID-19
    LeBras, Marlys
    Crawley, Alex
    Legge, Marc
    Takaya, Satchan
    Lee, Stephen
    Regier, Loren
    CANADIAN FAMILY PHYSICIAN, 2023, 69 (08) : 546 - 549
  • [4] Nirmatrelvir-Ritonavir and Viral Load Rebound in Covid-19
    Anderson, Annaliesa S.
    Caubel, Patrick
    Rusnak, James M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (11): : 1047 - 1049
  • [5] Rebound of COVID-19 With Nirmatrelvir-Ritonavir Antiviral Therapy
    Cohen, Myron S.
    Brown, Elizabeth R.
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (12) : 1672 - 1673
  • [6] Oral Nirmatrelvir-Ritonavir as Postexposure Prophylaxis for Covid-19
    Hammond, Jennifer
    Yunis, Carla
    Fountaine, Robert J.
    Luscan, Gerald
    Burr, Aimee M.
    Zhang, Wuyan
    Wisemandle, Wayne
    Soares, Holly
    Baniecki, Mary Lynn
    Hendrick, Victoria M.
    Kalfov, Veselin
    Pypstra, Rienk
    Rusnak, James M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (03): : 224 - 234
  • [7] In outpatients with COVID-19 during Omicron variant circulation, molnupiravir and nirmatrelvir-ritonavir improved outcomes
    Chagla, Zain
    ANNALS OF INTERNAL MEDICINE, 2024, 177 (01) : JC7 - JC7
  • [8] VV116 versus Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19
    Cao, Zhujun
    Gao, Weiyi
    Bao, Hong
    Feng, Haiyan
    Mei, Shuya
    Chen, Peizhan
    Gao, Yueqiu
    Cui, Zhilei
    Zhang, Qin
    Meng, Xianmin
    Gui, Honglian
    Wang, Weijing
    Jiang, Yimei
    Song, Zijia
    Shi, Yiqing
    Sun, Jing
    Zhang, Yifei
    Xie, Qing
    Xu, Yiping
    Ning, Guang
    Gao, Yuan
    Zhao, Ren
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (05): : 406 - 417
  • [9] Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in CKD Patients With COVID-19
    Cheng, Franco Wing Tak
    Yan, Vincent Ka Chun
    Wan, Eric Yuk Fai
    Chui, Celine Sze Ling
    Lai, Francisco Tsz Tsun
    Wong, Carlos King Ho
    Li, Xue
    Zhang, Irene Ran
    Tang, Sydney Chi Wai
    Wong, Ian Chi Kei
    Chan, Esther Wai Yin
    KIDNEY INTERNATIONAL REPORTS, 2024, 9 (05): : 1244 - 1253
  • [10] Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Hospitalized Patients With COVID-19
    Focosi, Daniele
    Nicastri, Emanuele
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (10)
12345